Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories. [PDF]
Oldenburg J +9 more
europepmc +1 more source
An ER stress-responsive RNA rheostat for programmable gene and mRNA therapies. [PDF]
Ogurlu R +13 more
europepmc +1 more source
A miniaturized chemiluminescent thrombin generation assay to assess the effect of APCC in persons with hemophilia A with inhibitors: an observational study. [PDF]
Bavinck AP +10 more
europepmc +1 more source
Perioperative hemostasis management in patients with von Willebrand disease undergoing cardiac surgery: A scoping review. [PDF]
Loskutov O +6 more
europepmc +1 more source
A revised classification of FVIII concentrates: rationale and novel metrics. [PDF]
Hermans C +5 more
europepmc +1 more source
Multicentre Retrospective and Prospective Analysis of Data on Emicizumab and Factor VIII Prophylaxis in Children With Severe Haemophilia A: Egypt-Compare Study. [PDF]
Hassan T +7 more
europepmc +1 more source
Frequency of type 2N von Willebrand disease among patients with mild or moderate factor VIII deficiency in an 18-month period in Iran. [PDF]
Azari B, Mirakhorli M, Ahmadinejad M.
europepmc +1 more source
Popping FVIII concentrates into an updated classification. [PDF]
Croteau SE.
europepmc +1 more source
Haemophilia A in a Female German Shepherd With Homozygosity for the FVIII p.C567Y Variant in Exon 11 of the F8 Gene. [PDF]
Brenig B, Pach S.
europepmc +1 more source
Gene Silencing of ANGPTL3 Induces PCSK9: Exploring the Biological Significance in the Hepatoma Huh7 Cell Line. [PDF]
Rossi I +8 more
europepmc +1 more source

